High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors

被引:54
作者
Wilcox, CB [1 ]
Baysal, BE [1 ]
Gallion, HH [1 ]
Strange, MA [1 ]
DeLoia, JA [1 ]
机构
[1] Magee Womens Res Inst, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15213 USA
关键词
D O I
10.1016/j.cancergencyto.2004.12.017
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Both hereditary and sporadic ovarian tumors frequently have decreased BRCA1 expression. One mechanism of downregulating BRCA1 expression is hypermethylation of the BRCA1 promoter. Studies have shown that the BRCA1 promoter is aberrantly hypermethylated in a subset of ovarian tumors, although the proportion varies widely between reports. High-resolution analysis of the BRCA1 promoter in ovarian cancer may provide information regarding the extent and heterogeneity of methylation and guide future studies using methylation-specific polymerase chain reaction (MSPCR). We screened 50 primary epithelial ovarian tumors for BRCA1 promoter hypermethylation using MS-PCR. The BRCA1 promoter was hypermethylated in 16% (8 of 50) of the tumors, including two stage IA tumors. Sequence analysis of the promoter revealed that methylation of the CpG island is both extensive and mosaic in the methylated samples. Two CpG dinucleotides in the BRCA1 promoter, within and adjacent to a Myb consensus binding site, were most frequently methylated in ovarian tumors. BRCA1 expression was significantly lower in methylated than in unmethylated samples. Our analysis of the BRCA1 promoter revealed preferential methylation of specific CpG sites in ovarian tumors. This finding could be exploited in the design of highly sensitive MS-PCR assays for direct assessment of tumor DNA and potentially for early detection of ovarian cancer in body fluids. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:114 / 122
页数:9
相关论文
共 50 条
  • [1] A CREB site in the BRCA1 proximal promoter acts as a constitutive transcriptional element
    Atlas, E
    Stramwasser, M
    Mueller, CR
    [J]. ONCOGENE, 2001, 20 (48) : 7110 - 7114
  • [2] Baldwin RL, 2000, CANCER RES, V60, P5329
  • [3] GENITAL HUMAN PAPILLOMAVIRUS INFECTION IN FEMALE UNIVERSITY-STUDENTS AS DETERMINED BY A PCR-BASED METHOD
    BAUER, HM
    TING, Y
    GREER, CE
    CHAMBERS, JC
    TASHIRO, CJ
    CHIMERA, J
    REINGOLD, A
    MANOS, MM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (04): : 472 - 477
  • [4] Berchuck A, 1998, CLIN CANCER RES, V4, P2433
  • [5] Chan KYK, 2002, CANCER RES, V62, P4151
  • [6] Costello JF, 1996, CANCER RES, V56, P2405
  • [7] de Caceres Inmaculada Ibanez, 2004, Cancer Research, V64, P6476, DOI 10.1158/0008-5472.CAN-04-1529
  • [8] Functional analysis of CpG methylation in the BRCA1 promoter region
    DiNardo, DNM
    Butcher, DT
    Robinson, DP
    Archer, TK
    Rodenhiser, DI
    [J]. ONCOGENE, 2001, 20 (38) : 5331 - 5340
  • [9] Dobrovic A, 1997, CANCER RES, V57, P3347
  • [10] Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors
    Esteller, M
    Silva, JM
    Dominguez, G
    Bonilla, F
    Matias-Guiu, X
    Lerma, E
    Bussaglia, E
    Prat, J
    Harkes, IC
    Repasky, EA
    Gabrielson, E
    Schutte, M
    Baylin, SB
    Herman, JG
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (07): : 564 - 569